![Stephen M. Restaino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen M. Restaino
Amministratore Delegato presso Sonosa Medical, Inc.
Profilo
Stephen M.
Restaino is the founder of Sonosa Medical, Inc. and currently holds the title of Chief Executive Officer.
Posizioni attive di Stephen M. Restaino
Società | Posizione | Inizio |
---|---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Amministratore Delegato | 01/11/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Stephen M. Restaino